Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jun. 30, 2025
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Dr. Ann S. Blouin [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | Dr. Ann S. Blouin, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on May 02, 2025. Dr. Blouin's 10b5-1 Plan provides for the potential sale of up to 425 shares of the Company's common stock between July 31, 2025 and April 30, 2026. |
| Name | Dr. Ann S. Blouin |
| Title | a member of our Board of Directors |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | May 02, 2025 |
| Expiration Date | April 30, 2026 |
| Arrangement Duration | 273 days |
| Aggregate Available | 425 |
| Daren J. Shaw [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | Daren J. Shaw, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on May 7, 2025. Mr. Shaw's 10b5-1 Plan provides for the potential sale of up to 4,000 shares of the Company's common stock between August 15, 2025 and May 29, 2026. |
| Name | Daren J. Shaw |
| Title | a member of our Board of Directors |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | May 7, 2025 |
| Expiration Date | May 29, 2026 |
| Arrangement Duration | 287 days |
| Aggregate Available | 4,000 |